[1]彭琪彦.慢性肾脏病患者RBP与T淋巴细胞亚群 检测的临床意义[J].医学信息,2019,32(18):91-93.[doi:10.3969/j.issn.1006-1959.2019.18.029]
　PENG Qi-yan.Clinical Significance of Detection of RBP and T Lymphocyte Subsets in Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(18):91-93.[doi:10.3969/j.issn.1006-1959.2019.18.029]
点击复制

慢性肾脏病患者RBP与T淋巴细胞亚群 检测的临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年18期
页码:
91-93
栏目:
临床研究
出版日期:
2019-09-15

文章信息/Info

Title:
Clinical Significance of Detection of RBP and T Lymphocyte Subsets in Patients with Chronic Kidney Disease
文章编号:
1006-1959（2019）18-0091-03
作者:
彭琪彦
湖北省应城市人民医院病理科，湖北 应城 432400
Author(s):
PENG Qi-yan
Department of Pathology,Yingcheng People's Hospital,Yingcheng432400,Hubei,China
关键词:
慢性肾脏病; 分期; 视黄醇结合蛋白; T淋巴细胞
Keywords:
Key words：Chronic kidney disease; Staging; Retinol binding protein; T lymphocytes
分类号:
R692；R446.6
DOI:
10.3969/j.issn.1006-1959.2019.18.029
文献标志码:
A
摘要:
目的 探讨慢性肾脏病（CKD）不同分期患者视黄醇结合蛋白（RBP）与T淋巴细胞亚群检测的临床意义。方法 选取2017年1月~2018年11月收治于应城市人民医院肾内科住院356例CKD患者设为CKD组，另选同期55例健康体检者设为对照组，其中CKD组根据肾小球滤过率水平分为五期，根据五期分为相应五组，依次分为CKD1组、CKD2组、CKD3组、CKD4组、CKD5组，五组病情逐渐加重，检测其外周血CD3+、CD4+、CD8+T淋巴细胞绝对数与RBP、Cr、UA、β2-MG并比较。结果 CKD组患者CD3+、CD4+低于对照组，差异有统计学意义（P＜0.05）；两组CD8+比较，差异无统计学意义（P＞0.05）；CKD各期CD3+、CD4+、CD8+计数比较，差异有统计学意义（P＜0.05）；CKD组Cr、β2-MG分别低于对照组，RBP、UA分别高于对照组，差异有统计学意义（P＜0.05）；RBP与CD3+、CD4+、CD8+均呈正相关（P＜0.05）；Cr与CD3+、CD4+、CD8+均呈负相关（P＜0.05）；UA与CD3+、CD4+、CD8+均呈正相关（P＜0.05）。结论 从CKD1期发展至CKD5期过程中，患者血清RBP逐渐降低，细胞免疫功能下降，且与CKD分期密切相关。
Abstract:
Abstract：Objective To investigate the clinical significance of detection of retinol binding protein (RBP) and T lymphocyte subsets in patients with different stages of chronic kidney disease (CKD).Methods From January 2017 to November 2018, 356 patients with CKD admitted to the Department of Nephrology, Yingcheng People's Hospital were enrolled in the CKD group. Another 55 healthy subjects were selected as the control group. The CKD group was based on glomerular filtration. The over-rate level was divided into five stages. According to the five stages, it was divided into five groups, which were divided into CKD1 group, CKD2 group, CKD3 group, CKD4 group and CKD5 group. The five groups gradually became more serious, and their peripheral blood CD3+, CD4+,CD8+ T the absolute number oflymphocytes was compared with RBP, Cr, UA, and β2-MG.Results The CD3+ and CD4+ levels in the CKD group were significantly lower than those in the control group,the difference was statistically significant (P<0.05). There was no significant difference in CD8+ between the two groups (P>0.05). The differences of CD3+, CD4+ and CD8+counts in CKD were statistically significant (P<0.05). CKD The levels of Cr and β2-MG were lower than those of the control group, and the RBP and UA were higher than the control group, the difference was statistically significant (P<0.05). The RBP was positively correlated with CD3+, CD4+ and CD8+ (P<0.05).There was a significant negative correlation between Cr and CD3+, CD4+ and CD8+(P<0.05). There was a significant positive correlation between UA and CD3+, CD4+ and CD8+ (P<0.05).Conclusion During the progression from CKD1 to CKD5, serum RBP is gradually decreased, cellular immune function is decreased, and it is closely related to CKD stage.

参考文献/References:

[1]Caby F.Writing committee of the CD4+/CD8 +ratio restoration in long-term treated HIV-1-infected individuals:Incidence and determinants[J].AIDS,2017,31(12):1685. [2]Vaziri ND.Oxidative stress in uremia: nature, mechanisms,and potential consequences[J].Semin Nephrol,2004,24(5):469-473. [3]Badious S,Cristol JP,Jaussent I,et al.Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination[J].Clin T Am Soc Nephrol,2008,3(2):423-430. [4]National Kidney Foundation.KDOQI clinical practice guideline for diabetes and CKD:2012 Update[J].Am J Kidey Dis,2012,60(5):850. [5]谭政,龚非力.T细胞功能亚群[J].生命科学,2010,22(6):499. [6]吴姗姗,严 峰,邓玉玲,等.小细胞和非小细胞肺癌晚期患者CD3+CD4+及CD3+CD8+T淋巴细胞亚群的差异[J].中国免疫学杂志,2015,31(1):114. [7]Sallustio F,Serino G,Cox SN,et al.Aberrantly methylated DNA regions lead to low activation of CD4+T cell sin IgA nephropathy[J].ClinSci(Lond),2016,130(9):733. [8]Humrich JY,Kamradt T,Riemekasten G.Regulatory T cells and rheumatic diseases[J].Z Rheumatol,2015,74(1):26-32． [9]Ueyama A,Immura C,Fusamae T,et al.Potential role of IL-17-producing CD4/CD8 double negative alphabeta T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model[J].J Dermatol Sci,2017,85(1):27-35.

相似文献/References:

[1]谢 琴.肾小球C4d沉积在慢性肾病早期诊断及预后的价值分析[J].医学信息,2018,31(08):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
　XIE Qin.Value of Glomerular C4d Deposition in Early Diagnosis and Prognosis of Chronic Kidney Disease[J].Journal of Medical Information,2018,31(18):81.[doi:10.3969/j.issn.1006-1959.2018.08.025]
[2]钟 旭.慢性肾脏病相关神经精神疾病的研究[J].医学信息,2022,35(11):51.[doi:10.3969/j.issn.1006-1959.2022.11.015]
　ZHONG Xu.Study on Neuropsychiatric Diseases Associated with Chronic Kidney Disease[J].Journal of Medical Information,2022,35(18):51.[doi:10.3969/j.issn.1006-1959.2022.11.015]
[3]许书凡,庞 华.18F-FDGPET/CT在卵巢癌中的应用研究[J].医学信息,2019,32(08):75.[doi:10.3969/j.issn.1006-1959.2019.08.022]
　XU Shu-fan,PANG Hua.Research on the Application of 18F-FDGPET/CT in Ovarian Cancer[J].Journal of Medical Information,2019,32(18):75.[doi:10.3969/j.issn.1006-1959.2019.08.022]
[4]李 尤,王子卫.食管胃结合部腺癌的研究进展[J].医学信息,2019,32(13):39.[doi:10.3969/j.issn.1006-1959.2019.13.013]
　LI You,WANG Zi-wei.Advances in Research on Esophageal and Gastric Junction Adenocarcinoma[J].Journal of Medical Information,2019,32(18):39.[doi:10.3969/j.issn.1006-1959.2019.13.013]
[5]徐海红,刘 宇,宋桂云.腹膜透析患者认知功能障碍对日常透析操作影响的研究[J].医学信息,2022,35(15):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
　XU Hai-hong,LIU Yu,SONG Gui-yun.Study on the Effect of Cognitive Dysfunction in Peritoneal Dialysis Patients on Daily Dialysis Operation[J].Journal of Medical Information,2022,35(18):110.[doi:10.3969/j.issn.1006-1959.2022.15.025]
[6]崔方强.足细胞上皮间质转分化研究[J].医学信息,2019,32(22):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
　CUI Fang-qiang.Epithelial Transdifferentiation of Podocytes[J].Journal of Medical Information,2019,32(18):21.[doi:10.3969/j.issn.1006-1959.2019.22.008]
[7]高 彬,孙 娜,常文秀.慢性肾脏病患者血钾异常相关因素分析[J].医学信息,2019,32(22):91.[doi:10.3969/j.issn.1006-1959.2019.22.027]
　GAO Bin,SUN Na,CHANG Wen-xiu.Analysis of Related Factors of Serum Potassium Abnormality in Patients with Chronic Kidney Disease[J].Journal of Medical Information,2019,32(18):91.[doi:10.3969/j.issn.1006-1959.2019.22.027]
[8]王希敏.2型糖尿病并发慢性肾脏病患者外周血T淋巴细胞亚群变化与肾血管内皮功能障碍的相关 分析[J].医学信息,2021,34(23):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
　WANG Xi-min.Correlation Analysis of T Lymphocyte Subsets in Peripheral Blood with Renal Vascular Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus Complicated with Chronic Kidney Disease[J].Journal of Medical Information,2021,34(18):77.[doi:10.3969/j.issn.1006-1959.2021.23.021]
[9]袁 娟,赫英龙.参芎葡萄糖与前列地尔治疗慢性肾脏病的疗效比较[J].医学信息,2020,33(14):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
　YUAN Juan,HE Ying-long.Comparison of Curative Effect between Shenqiong Glucose and Alprostadil in Treating Chronic Kidney Disease[J].Journal of Medical Information,2020,33(18):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
[10]倪 曼.非布司他与别嘌醇治疗慢性肾脏病合并高尿酸血症的疗效比较[J].医学信息,2020,33(15):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]
　NI Man.Comparison of the Efficacy of Febuxostat Tablets and Allopurinol in the Treatment of Chronic Kidney Disease with Hyperuricemia[J].Journal of Medical Information,2020,33(18):140.[doi:10.3969/j.issn.1006-1959.2020.15.043]

更新日期/Last Update: 2019-09-15